{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:37Z","timestamp":1792787917121,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Whole blood transfusion is increasingly used in trauma resuscitation. However, stored whole blood units demonstrate increasing susceptibility to tissue plasminogen activator\u2013mediated fibrinolysis despite paradoxical increases seen in plasminogen activator inhibitor\u20131 (PAI-1) activity over time. Whether early variability in PAI-1activity exists across whole blood units and the biologic contributors to this variability remain unclear. Two distinct donor pools were identified: one with high PAI-1 activity and one with low PAI-1 activity. We set out to determine whether PAI-1 activity in whole blood donors primarily comes from the endothelium or from platelet degranulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Plasma from whole blood units (n = 28) was generated via serial centrifugation at two time points during storage (Days 1\u20133 and Day 21). Activity assays were performed for PAI-1 using a modified enzyme-linked immunosorbent assays that only captures active PAI-1. Soluble CD40 ligand (sCD40L), a platelet-derived marker of activation, degranulation and death, and total von Willebrand Factor antigen levels, which are highly specific for endothelial degranulation, were quantified using enzyme-linked immunosorbent assays. Statistical analysis was performed via two-tailed t-tests. Significance was set at\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt;0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Whole blood units stratified into distinct high and low PAI-1 activity cohorts at early storage time points. Over storage, PAI-1 activity increased overall. sCD40L levels increased approximately 4-fold during storage, consistent with a platelet storage lesion. At early time points, both sCD40L and von Willebrand Factor antigen levels were significantly higher in the high PAI-1 cohort, suggesting contributions from both platelet-derived and donor endothelial factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Stored whole blood demonstrates early, donor-dependent heterogeneity in antifibrinolytic potential, reflected by distinct PAI-1 activity cohorts at time of donation. This appears to have a mixed source, with evidence for both endothelial and platelet factors that may differ from donor to donor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000005012","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:00:32Z","timestamp":1776952832000},"page":"769-776","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Platelet storage lesion underlies changes in plasminogen activator inhibitor\u20131 activity in stored whole blood"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3697-3185","authenticated-orcid":false,"given":"Elizabeth R.","family":"Maginot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolle K.","family":"Barmettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flobater I.","family":"Gawargi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan C.","family":"Hiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle S.","family":"Sextro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trace B.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter B.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleh","family":"Bobr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynold","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-8155","authenticated-orcid":false,"given":"Christopher D.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"issue":"7-8","key":"R1-20261023","doi-asserted-by":"crossref","first-page":"usab473","DOI":"10.1093\/milmed\/usab473","article-title":"Ranger O low titer (ROLO): whole blood transfusion for forward deployed units","volume":"188","author":"Song","year":"2023","journal-title":"Mil Med"},{"issue":"1","key":"R2-20261023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/TA.0000000000002498","article-title":"Safety profile and impact of low-titer group O whole blood for emergency use in trauma","volume":"88","author":"Williams","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"R3-20261023","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jamasurg.2022.6978","article-title":"Association of whole blood with survival among patients presenting with severe hemorrhage in US and Canadian adult civilian trauma centers","volume":"158","author":"Torres","year":"2023","journal-title":"JAMA Surgery"},{"issue":"2","key":"R4-20261023","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/TA.0000000000002753","article-title":"Nationwide analysis of whole blood hemostatic resuscitation in civilian trauma","volume":"89","author":"Hanna","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"R5-20261023","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"R6-20261023","article-title":"Whole blood becomes increasingly susceptible to tPA-mediated fibrinolysis with storage","volume":"100","author":"Maginot","year":"2025","journal-title":"J Trauma Acute Care Surg"},{"key":"R7-20261023","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000004526","article-title":"The tissue-plasminogen activator-challenged thromboelastography provides a comprehensive assessment of fibrinolysis in the severely injured","volume":"98","author":"Maginot","year":"2025","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R8-20261023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/TA.0000000000000885","article-title":"Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients","volume":"80","author":"Chapman","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"R9-20261023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/TA.0b013e31825c1234","article-title":"Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration","volume":"73","author":"Cotton","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"R10-20261023","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jamcollsurg.2016.01.006","article-title":"Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients","volume":"222","author":"Moore","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"1","key":"R11-20261023","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/XCS.0000000000001027","article-title":"Differentiating pathologic from physiologic fibrinolysis: not as simple as conventional thrombelastography","volume":"239","author":"Moore","year":"2024","journal-title":"J Am Coll Surg"},{"key":"R12-20261023","doi-asserted-by":"crossref","first-page":"622473","DOI":"10.3389\/fcvm.2020.622473","article-title":"Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition","volume":"7","author":"Sillen","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"R13-20261023","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0042-1758791","article-title":"Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1)","volume":"49","author":"Morrow","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"R14-20261023","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","article-title":"The CD40\/CD40 ligand system: linking inflammation with atherothrombosis","volume":"54","author":"Antoniades","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"R15-20261023","doi-asserted-by":"crossref","first-page":"22342","DOI":"10.3390\/ijms151222342","article-title":"The signaling role of CD40 ligand in platelet biology and in platelet component transfusion","volume":"15","author":"Aloui","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"R16-20261023","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jth.12225","article-title":"The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story","volume":"11","author":"Nightingale","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"2","key":"R17-20261023","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0008-6363(97)00039-4","article-title":"von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?","volume":"34","author":"Lip","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"2","key":"R18-20261023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","article-title":"Inflammation, von Willebrand factor, and ADAMTS13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"issue":"2","key":"R19-20261023","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/vox.13005","article-title":"Whole blood haemostatic function throughout a 28-day cold storage period: an in vitro study","volume":"116","author":"McRae","year":"2021","journal-title":"Vox Sang"},{"issue":"6","key":"R20-20261023","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/SHK.0000000000000161","article-title":"Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients","volume":"41","author":"Cardenas","year":"2014","journal-title":"Shock"},{"issue":"6","key":"R21-20261023","first-page":"969","article-title":"Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins","volume":"100","author":"Kruithof","year":"2008","journal-title":"Thromb Haemost"},{"key":"R22-20261023","doi-asserted-by":"crossref","first-page":"653655","DOI":"10.3389\/fcvm.2021.653655","article-title":"A serpin with a finger in many PAIs: PAI-1\u2019s central function in thromboinflammation and cardiovascular disease","volume":"8","author":"Morrow","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R23-20261023","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2741\/2285","article-title":"Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis","volume":"12","author":"Aso","year":"2007","journal-title":"Front Biosci"},{"issue":"6","key":"R24-20261023","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0034-1384635","article-title":"Plasminogen activator inhibitor-1 in aging","volume":"40","author":"Yamamoto","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"R25-20261023","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/TA.0000000000002040","article-title":"The procoagulant molecule plasminogen activator inhibitor-1 is associated with injury severity and shock in patients with and without traumatic brain injury","volume":"85","author":"Condron","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R26-20261023","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.thromres.2014.04.013","article-title":"Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients","volume":"134","author":"Lorente","year":"2014","journal-title":"Thromb Res"},{"issue":"12","key":"R27-20261023","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1016\/j.jtha.2024.08.024","article-title":"Resistance to tPA-induced fibrinolysis and activation of coagulation is present in autoimmune bullous diseases of the skin","volume":"22","author":"Sharma","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"2","key":"R28-20261023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tmrv.2016.01.002","article-title":"Effect of blood donor characteristics on transfusion outcomes: a systematic review and meta-analysis","volume":"30","author":"Chass\u00e9","year":"2016","journal-title":"Transfus Med Rev"},{"issue":"10","key":"R29-20261023","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/vox.13507","article-title":"Association of blood donor characteristics and in vitro haemolysis of packed red blood cell concentrates during storage","volume":"118","author":"Dhawan","year":"2023","journal-title":"Vox Sang"},{"issue":"1","key":"R30-20261023","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tmrv.2017.07.006","article-title":"Exploring donor and product factors and their impact on red cell post-transfusion outcomes","volume":"32","author":"Ning","year":"2018","journal-title":"Transfus Med Rev"},{"issue":"8","key":"R31-20261023","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.3390\/ijms22083943","article-title":"Current understanding of the relationship between blood donor variability and blood component quality","volume":"22","author":"Hadjesfandiari","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"R32-20261023","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamainternmed.2016.3324","article-title":"Association of blood donor age and sex with recipient survival after red blood cell transfusion","volume":"176","author":"Chass\u00e9","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"6","key":"R33-20261023","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jamainternmed.2017.0890","article-title":"Association of donor age and sex with survival of patients receiving transfusions","volume":"177","author":"Edgren","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"15","key":"R34-20261023","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJMoa2211523","article-title":"Effect of donor sex on recipient mortality in transfusion","volume":"388","author":"Chass\u00e9","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"R35-20261023","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tmrv.2020.09.007","article-title":"Quality of platelets in stored whole blood","volume":"34","author":"van der Meer","year":"2020","journal-title":"Transfus Med Rev"},{"issue":"S2","key":"R36-20261023","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/trf.15164","article-title":"Optimizing whole blood storage: hemostatic function of 35-day stored product in CPD, CP2D, and CPDA-1 anticoagulants","volume":"59","author":"Meledeo","year":"2019","journal-title":"Transfusion (Paris)"},{"issue":"Suppl 1","key":"R37-20261023","first-page":"S111","article-title":"Coagulation function of never frozen liquid plasma stored for 40\u00a0days","volume":"61","author":"Meledeo","year":"2021","journal-title":"Transfusion (Paris)"},{"issue":"6","key":"R39-20261023","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/trf.15302","article-title":"Platelets stored in whole blood at 4\u00b0C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function","volume":"59","author":"Slichter","year":"2019","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"R40-20261023","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/09537104.2020.1869715","article-title":"A novel approach to laboratory assessment and reporting of platelet von Willebrand factor","volume":"33","author":"Kragh","year":"2022","journal-title":"Platelets"},{"issue":"8","key":"R41-20261023","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2012.04797.x","article-title":"Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis","volume":"10","author":"Kanaji","year":"2012","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000005012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:01:10Z","timestamp":1792785670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000005012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000005012","relation":{},"ISSN":["2163-0755","2163-0763"],"issn-type":[{"value":"2163-0755","type":"print"},{"value":"2163-0763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"2026-01-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}